Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure

Inclusion Criteria: * Diagnosed with Amnestic Mild Cognitive Impairment within the past 12 months, * Available PET Aβ and tau imaging Exclusion Criteria: * Significant neurologic diagnosis (e.g., Alzheimer's dementia or other neurodegenerative dementia, Parkinson's disease, seizure disorder, tumor, multiple sclerosis) * Neurologic injury (e.g., significant stroke or moderate-severe head injury, defined by loss of consciousness \> 5 minutes, presence of significant post-traumatic amnesia, or the need for extended hospitalization or intervention) * Motor abnormalities indicative of a non-AD etiology * Severe mental illness (e.g., bipolar disorder, psychosis), moderate-severe mood or anxiety disorder, active substance use disorder (o reduce the likelihood of severe psychological distress, participants must screen negative for moderate-severe depressive or anxiety symptoms at study enrollment.) * Inability to provide independent informed consent.